ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

TBPH Theravance Biopharma Inc

8.34
-0.21 (-2.46%)
May 24 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 355.36M360.76M763.5M607.4M538.55M446.63M413.59M382M
Total Current Assets 204.64M154.73M511.72M353.46M261.34M192M161.69M133.54M
Cash and Equivalents 94.37M87.29M418.54M298.17M187.67M105.6M71.69M39.55M
Total Non-Current Assets 150.72M206.03M251.78M265.81M277.21M254.63M251.9M257.53M
Total Liabilities 706.81M710.57M282.92M165.6M167.99M166.47M167.46M169M
Total Current Liabilities 44.2M32.62M142.13M28.72M26.18M24.55M25.37M24.77M
Total Non-Current Liabilities 1.28B1.3B140.79M136.89M141.81M141.92M142.09M144.24M
Common Equity 1,0001,0001,0001,0001,0001,0001,0000
Retained Earnings -1.75B-1.76B-843.55M-853.91M-876M-891.64M-900.59M-909.1M
Year End December 30 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 639.25M441.4M560.24M408.83M469.06M374.82M607.4M382M
Total Current Assets 528.5M378.75M532.82M338.49M393.34M249.87M353.46M133.54M
Cash and Equivalents 344.71M88.98M378.02M58.06M81.47M89.96M298.17M39.55M
Total Non-Current Assets 350.23M115.18M-51.59M-223.84M-303.75M-338.57M441.8M213M
Total Liabilities 289.02M326.22M611.82M632.67M772.81M713.39M165.6M169M
Total Current Liabilities 49.27M62.55M98.55M111.7M123.57M58.59M28.72M24.77M
Total Non-Current Liabilities 463.33M487.42M967.62M966.15M1.25B1.25B136.89M144.24M
Total Equity 350.23M115.18M-51.59M-223.84M-303.75M-338.57M441.8M213M
Common Equity 1,0001,0001,0001,0001,0001,0001,0000
Retained Earnings -512.23M-797.74M-1.01B-1.25B-1.53B-1.73B-853.91M-909.1M